Legal Representation
Attorney
Peter M. Brody
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 19, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 19, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 10, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 10, 2005 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 10, 2005 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 21, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 6, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 6, 2004 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 26, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 24, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| May 12, 2004 | I | PAPER RECEIVED | Loading... | |
| May 11, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 28, 2004 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 21, 2003 | I | PAPER RECEIVED | Loading... | |
| Oct 21, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 14, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 29, 2003 | I | PAPER RECEIVED | Loading... | |
| Apr 29, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 12, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 20, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 31, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 12, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 20, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 9, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 3, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jul 26, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Calcium phosphate sold as an integral component of pharmaceuticals for use as a drug delivery preparation
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
GENTEX
Classification
International Classes
005